Guardant Health snagged the FDA green light to use its Guardant360 CDx colon cancer diagnostic along with Pfizer’s colon and skin cancer drug Braftovi in combination with cetuximab and chemotherapy.

To investigate the use of celecoxib on disease-free survival in patients with stage 3 colon cancer, Meyerhardt and colleagues initiated a randomized clinical trial, the CALGB (Alliance)/SWOG 80702 ...

Drinking alcohol is linked to higher chances of colorectal cancer − but just how many drinks increase your risk? New research, published Jan. 26 in the American Cancer Society's peer-reviewed journal ...

Hong Kong’s workforce lags behind regional peers in the frequent use of artificial intelligence, a sluggish adoption rate that experts say are limiting pay rewards and job security even as companies ...

A new study published Monday (January 26) in the journal Cancer finds that heavy, long-term alcohol use can significantly raise the risk of colorectal cancer. According to researchers, people who ...

Paint sprayers require more of a learning curve than a paint roller and tray, but their speed and efficiency are well worth the time you invest to practice. With a specialized nozzle that transforms ...